Low expression or inactivated mutation of Keap1 occurs in human non-small-cell lung carcinoma tissues including adenocarcinoma, leading to the increased expression and activation of Nrf2 [26,27]. This evidence concerns the gene NFE2L2 and adenocarcinoma.